Published in Lab Business Week, January 23rd, 2005
All of the shares are being offered by Adeza.
Adeza has granted to the underwriters a 30-day option to purchase up to an additional 562,500 shares at the initial public offering price to cover over-allotments, if any.
UBS Securities LLC is acting as the sole book-running manager of the offering. SG Cowen & Co., Thomas Weisel Partners LLC and William Blair & Company are acting as comanagers of the offering.
This article was prepared by Lab Business Week...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.